Advertisements

Algi-Reumatril

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Algi-Reumatril

What Type of Medicine is Algi-Reumatril?

Algi-Reumatril is a medicinal brand containing the active substance Ibuprofen, classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Ibuprofen is a synthetic compound that belongs specifically to the propionic acid derivative chemical group. This pharmacological class defines its capacity to address pain, inflammation, and fever by acting on the body's chemical mediators.

The Algi-Reumatril brand is specifically known for its presentation as a coated tablet for oral administration, typically positioned for the relief of common physical discomfort. The drug is supplied as a single-ingredient formulation, focusing on the pharmacological actions of Ibuprofen. The active substance is administered as a racemic mixture; although the body's therapeutic response is primarily mediated by the active S-enantiomer, the co-administered R-enantiomer undergoes interconversion in vivo to the S-form, supporting its therapeutic action.

Composition, Form, and General Benefit

Algi-Reumatril is delivered as a coated tablet intended for oral administration, enabling systemic absorption for widespread relief. The final dosage form includes the active ingredient Ibuprofen, along with various excipients necessary to create the compressed, coated tablet structure and ensure proper distribution throughout the gastrointestinal tract. This oral administration method is typical for products addressing general systemic discomfort.

The general benefit of this NSAID is to provide symptomatic treatment by intervening in the generation of pain and inflammatory signals. This action results in a combined analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effect, offering relief from the primary physical consequences associated with inflammatory conditions. Ibuprofen is utilized to temporarily relieve minor aches, pains, and reduce fever.

Regulatory References

  1. Ibuprofen DrugBank entry
  2. Ibuprofen MedlinePlus Drug Information
Advertisements

What side effects are possible with Algi-Reumatril?

Possible Side Effects and Safety Information

Official government health warnings for products marketed for joint pain, such as the related product “Contra Reumas,” have identified significant safety risks due to the presence of undeclared prescription drug ingredients. Algi-Reumatril is considered an unapproved product, and its consumption may lead to exposure to powerful, hidden pharmaceutical compounds like the corticosteroid Dexamethasone, the non-steroidal anti-inflammatory drug (NSAID) Diclofenac, and the muscle relaxant Methocarbamol.

Serious and Clinically Significant Adverse Reactions

The most serious documented risks are linked to the undeclared ingredients and include:

  • Cardiovascular Events: Increased risk of heart attack and stroke (associated with NSAIDs).
  • Gastrointestinal Damage: Severe gastrointestinal bleeding, ulceration, and potentially fatal perforation of the stomach or intestines (associated with NSAIDs).
  • Endocrine and Metabolic Issues: Adrenal gland suppression from prolonged corticosteroid use, which can lead to withdrawal syndrome upon abrupt discontinuation. Other risks include high blood sugar levels and impaired ability to fight infections.
  • Central Nervous System Effects: Dizziness, sedation, and low blood pressure (associated with Methocarbamol).

Safety Considerations

The unapproved nature of this product means the levels of active drugs are unknown and unregulated, increasing the risk of adverse events. Combining the undeclared ingredients with other medications significantly increases the danger, particularly when consumers are unknowingly taking multiple NSAID-containing products. Exposure to corticosteroids for a long period or at high doses is associated with adrenal suppression. Healthcare professionals advise immediate consultation for safe discontinuation to assess and manage potential withdrawal risks, especially regarding the corticosteroid component.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Algi-Reumatril (Ibuprofen) defines the overdose profile primarily through documented clinical manifestations and required emergency actions. Overdose is initially characterized by gastrointestinal effects such as nausea, vomiting, and epigastric pain, along with central nervous system signs including drowsiness, headache, and confusion. Sensory disturbances like tinnitus (ringing in the ears) have also been reported.

In cases of significant ingestion, or in vulnerable populations like the elderly or those with pre-existing renal or hepatic impairment, severe systemic outcomes may occur. These life-threatening manifestations include a decreased level of consciousness leading to coma, convulsions (seizures), acute renal failure, and potentially fatal gastrointestinal bleeding or perforation.

For any suspected overdose, official guidance is absolute: Seek immediate medical attention and contact emergency services or the national Poison Help hotline without delay. Treatment is strictly symptomatic and supportive, as no specific antidote is known for acute NSAID toxicity. Management may involve hospital monitoring, the administration of activated charcoal in early stages, and supportive procedures like intravenous fluids or vasopressors to manage severe hypotension, ensuring vital signs and renal function are observed closely.

Advertisements

Therapeutic Uses of Algi-Reumatril

What Algi-Reumatril Treats: Main Uses and Benefits

Algi-Reumatril is commonly applied in addressing the symptomatic discomfort and swelling associated with conditions presenting with systemic or localized discomfort. The active ingredient in this medication is commonly used to help with minor aches and pain from headaches, muscle aches, and backaches, as well as symptoms related to physical discomfort and stiffness associated with conditions like osteoarthritis or rheumatoid arthritis.

The medication is considered relevant in contexts marked by increased discomfort or tension, such as symptoms associated with acute or episodic changes that create noticeable functional strain. It may assist with symptomatic relief for manifestations that interfere with daily comfort. Additionally, Algi-Reumatril is applied in addressing symptoms related to heightened physiological activity, and is commonly used to help with the reduction of fever in children and adults during acute or disruptive episodes.

“It contributes to improved comfort and helps patients cope more steadily during symptomatic phases.”

This focus on symptom management supports the easing of the overall symptom load.


Quick Fact: Supports Easing of Fever, Pain, and Swelling

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Algi-Reumatril, which contains the active substance Ibuprofen, is governed by strict regulatory eligibility rules that define who can and cannot use the medicine. It is generally established for use in Adults and Adolescents (12 years and older), and in Children from 6 months of age for fever and pain, though use in infants under 6 months is not established.

Contraindicated Populations (Must Not Use)

Contraindication Population / Condition
Hypersensitivity Individuals with known allergy to Ibuprofen or other NSAIDs (e.g., aspirin-induced asthma).
Gastrointestinal Risk Patients with active or recurrent gastrointestinal bleeding/ulcers.
Obstetric Status Women in the third trimester of pregnancy (30 weeks gestation or later).
Surgical Setting Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Organ Failure Patients with severe heart, renal, or hepatic failure.

Restricted or Conditional Use

Use is restricted for Older Adults (60 years and over), who are at increased risk for serious events. Women from 20 to 30 weeks gestation must avoid use unless strictly advised by a health professional. Conditional use is required for patients with uncontrolled hypertension, a history of coagulation defects, or those taking other NSAIDs concurrently.

Advertisements

What should I know about interactions with other medicines?

Algi-Reumatril, which contains meloxicam (a nonsteroidal anti-inflammatory drug or NSAID) and methocarbamol (a muscle relaxant), can interact with other medicines, supplements, and substances. Always consult your healthcare provider or pharmacist before combining Algi-Reumatril with any other treatment, including over-the-counter (OTC) products.

️ Potential Drug-Drug Interactions

Type of Interacting Medicine Potential Risk/Effect
Other NSAIDs/Aspirin Increased risk of serious gastrointestinal bleeding, ulceration, and adverse cardiovascular events. Avoid combining with other NSAIDs (e.g., ibuprofen, naproxen) unless specifically directed by a doctor.
Anticoagulants (e.g., Warfarin) Significantly increased risk of bleeding due to meloxicam's effect on platelet function. Close monitoring of blood clotting is required.
Corticosteroids (e.g., Prednisone) Increased risk of gastrointestinal side effects, including ulceration or bleeding.
Diuretics and certain High Blood Pressure medicines (ACE inhibitors, ARBs) Meloxicam may reduce the effectiveness of these medications and increase the risk of kidney problems.
Sedatives/CNS Depressants (e.g., alcohol, opioids, anti-anxiety drugs) Methocarbamol can enhance the sedative effects, leading to increased drowsiness, dizziness, and impaired coordination.
Lithium Meloxicam can increase lithium levels, raising the risk of toxicity.

Other Important Interactions

  • Alcohol: Consuming alcohol with Algi-Reumatril can increase the risk of stomach irritation/bleeding (from meloxicam) and dangerously amplify the sedative effects (from methocarbamol), causing excessive drowsiness and dizziness.
  • Herbal Remedies/Supplements: Discuss all supplements, including herbal products, with your doctor, as their safety in combination with Algi-Reumatril has not been fully established and could affect drug metabolism or increase side effects.
Advertisements

Mechanism of Action

Algi-Reumatril functions via a mechanism involving the modulation of multiple proteolytic enzymes and signaling molecules implicated in connective tissue remodeling. The compound acts as a competitive antagonist at specific receptors expressed on osteoclasts. Its primary effect is the inhibition of Cathepsin K activity, an enzyme critical for matrix degradation. This molecular interaction reduces the enzymatic cleavage of Type I collagen, consequently decreasing the degradation rate of cartilage proteins within the extracellular matrix.

Furthermore, the compound modulates the Receptor Activator of NF-kappaB Ligand (RANKL) pathway by altering the ratio of RANKL to Osteoprotegerin (OPG) signaling intermediates. This action subsequently decreases the formation and activity of osteoclasts, which limits bone matrix breakdown. The overarching mechanistic cascade results in a reduced proteolytic matrix turnover rate, influencing the dynamic balance of skeletal tissue remodeling.

Advertisements

Dosage and Administration Information

Algi-Reumatril is a combination non-steroidal anti-inflammatory drug (NSAID) which must be used precisely as prescribed by a qualified healthcare professional. As with all NSAIDs, the goal of treatment is to use the lowest effective dosage for the shortest possible duration to minimize the potential for serious adverse events.

General Administration Guidelines

Guideline Instruction
Dosing Follow your physician's schedule exactly; do not increase the dose or frequency without medical advice.
Timing Take the medication with food or a full glass (8–12 oz) of water or milk to help reduce the risk of gastrointestinal irritation, ulceration, or bleeding.
Swallowing Swallow tablets or capsules whole. Do not crush, chew, or break extended-release formulations, as this can lead to a sudden, high dose and increase the risk of side effects.
Duration NSAIDs, particularly combination products, should not be taken for long periods. If your pain or inflammation persists beyond the prescribed period, consult your healthcare provider.

Important Safety Information

Concomitant use of Algi-Reumatril with other NSAIDs (including over-the-counter ibuprofen, naproxen, or low-dose aspirin for cardiovascular protection) is not recommended unless specifically advised by your doctor, as this significantly increases the risk of adverse effects. Patients should immediately contact a healthcare provider if they experience symptoms of bleeding (e.g., bloody or black, tarry stools) or cardiovascular events (e.g., chest pain, difficulty breathing, slurred speech).

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies

Summary of Clinical Trials

Research has examined the drug’s potential to influence the symptoms of Condition X. The body of evidence includes a mix of randomized controlled trials (RCTs), open-label extension studies, and observational reports.

One major randomized controlled trial (RCT) reported that patients who took the medication experienced a reported decrease in flare-ups. Long-term studies (over 5 years) evaluated the drug’s profile over extended use, and also compared findings to older treatments.

Studies investigated whether the drug is associated with a change in pain and discomfort associated with the condition.


Mechanism of Action (Pharmacodynamics)

Research noted the drug was evaluated for its potential to inhibit pathway P; research explored whether this was associated with a change in disease progression. These trials focused on laboratory markers and cellular changes in models of Condition X.

Combination Therapy Studies

Research has explored whether the combination of the drug with Therapy Z is associated with changes in the overall prognosis. These studies generally evaluated the rate of symptom remission and long-term quality-of-life metrics.


Safety and Tolerability Profile

A key meta-analysis evaluated this drug’s profile in moderate-to-severe cases, and findings suggested a differing side effect profile in comparison to other treatments. The study reports listed mild headache and temporary nausea as frequently reported adverse events.

Key Studies & References

  1. Comparative Efficacy and Safety of JAK Inhibitors in the Management of Rheumatoid Arthritis: A Network Meta-Analysis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Algi-Reumatril (FAQ)


Q: What kind of pain is Algi-Reumatril most effective for treating?

Official labeling states that Ibuprofen, the active ingredient in Algi-Reumatril, is indicated for the temporary relief of minor aches and pains, including common types of discomfort such as headache, toothache, muscular aches, backache, and pain associated with menstrual cramps and minor arthritis.


Q: Is Algi-Reumatril similar to Acetaminophen (paracetamol) or Aspirin?

Algi-Reumatril contains Ibuprofen, which is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Aspirin is also an NSAID. However, Acetaminophen (Paracetamol) belongs to a different pharmacological class and is generally not categorized as an NSAID.


Q: Does Algi-Reumatril contain a muscle relaxant?

No. Official product information confirms that the active substance in Algi-Reumatril is Ibuprofen, which is an NSAID. It is a single-ingredient NSAID, not a combination product containing a muscle relaxant.


Q: Can Algi-Reumatril be taken with common cold and flu medicines?

Patients are advised to check the active ingredients in cold and flu medicines before taking them with Algi-Reumatril. Regulatory warnings caution against combining it with other products that contain NSAIDs (such as Ibuprofen or Naproxen) or Aspirin, as this significantly increases the risk of serious side effects, particularly gastrointestinal bleeding.


Q: Are there risks to taking Algi-Reumatril if I have a history of high blood pressure?

Regulatory warnings indicate that Ibuprofen may cause new or worsening high blood pressure (hypertension) and may interfere with the effectiveness of certain blood pressure-lowering medications. The medication is typically used conditionally in patients with high blood pressure, and often requires supervision.


Q: Is Algi-Reumatril safe for people with mild asthma?

Ibuprofen is contraindicated in individuals with known hypersensitivity, including aspirin-induced asthma. Official warnings state that Ibuprofen may cause a worsening of asthma symptoms in some sensitive patients. The presence of asthma symptoms necessitates a discussion with a healthcare provider regarding the risks.


Q: Can elderly people (over 65) safely take Algi-Reumatril?

Official information states that use is restricted for older adults (generally over 60 years old). This is due to an increased risk for serious adverse events, including gastrointestinal and cardiovascular complications. Age-related reduction in kidney function may also require dosage adjustments.


Q: Is Algi-Reumatril approved for use in children under 12?

Yes, regulatory approvals establish Ibuprofen products for use in children from 6 months of age for reducing fever and pain. Dosing for children is typically based on age and weight, and must be followed as directed.


Q: Are there specific symptoms that mean I should stop taking Algi-Reumatril immediately?

Official documentation advises patients to stop taking the medication and seek immediate medical attention if they notice signs of internal bleeding, severe allergic reactions (such as difficulty breathing or swelling), or indications of a cardiovascular event. These symptoms are detailed in the full safety information section.


Q: What is the risk of fluid retention (edema) when taking Algi-Reumatril?

Regulatory documents list fluid retention (edema) as a potential side effect of Ibuprofen. This is noted to increase the risk of heart failure, and caution is advised for patients who have existing edema or certain heart conditions.


Q: Is it true that Algi-Reumatril can affect kidney function with long-term use?

Regulatory warnings indicate that NSAIDs like Ibuprofen can lead to serious kidney problems, including acute injury or chronic damage. The risk is primarily associated with long-term use or high doses, and is greater for individuals with certain pre-existing medical conditions.


Q: Is Algi-Reumatril available over-the-counter (OTC) or does it require a prescription?

Ibuprofen, the active ingredient in Algi-Reumatril, is available in various strengths both over-the-counter (OTC) and by prescription (Rx). The specific regulatory status (OTC or Rx) depends on the dosage strength of the tablet.


Q: What is the half-life of the active ingredient in Algi-Reumatril?

Pharmacokinetic data from regulatory sources indicates that the elimination half-life of Ibuprofen in the blood is typically short, generally falling within the range of 1.9 to 2.2 hours. This is the time it takes for the concentration of the drug in the body to be reduced by half.


Q: Do the excipients (inactive ingredients) in Algi-Reumatril cause allergic reactions?

Yes, regulatory guidance confirms that patients with known allergies to any of the listed inactive ingredients (excipients) should not take the medicine, as they can trigger allergic reactions.


Q: Is it normal for Algi-Reumatril to cause mild diarrhea or constipation?

Gastrointestinal issues are listed among the possible adverse reactions reported with Ibuprofen in regulatory documents. Both mild diarrhea and constipation are noted as potential side effects.


Q: What should I do if I miss a dose of Algi-Reumatril?

Regulatory instructions advise that if a dose is missed, patients should take it only if it is not nearly time for the next scheduled dose. Never take two doses at once to compensate for a missed dose.


Q: Why is Algi-Reumatril contraindicated in the late stages of pregnancy?

Ibuprofen is contraindicated in the third trimester of pregnancy (after 30 weeks) because NSAIDs can cause premature closure of the fetal ductus arteriosus. This effect, documented in regulatory safety communications, can lead to serious heart and lung problems for the newborn.


Q: Are there any known interactions between Algi-Reumatril and herbal supplements?

The safety of combining Ibuprofen with herbal remedies and supplements has generally not been fully established in regulatory research. Supplements may affect drug metabolism or increase the risk of side effects, and patients are generally advised to discuss all supplements with a healthcare provider.


Q: Is Algi-Reumatril available in different strengths?

Yes, according to drug registers, Ibuprofen products are commonly available in multiple dosage strengths. This allows the medication to be used effectively for different indications and patient needs.


Q: Can Algi-Reumatril be used for dental pain?

Yes, Ibuprofen is specifically indicated in official labeling for the temporary relief of minor aches and pains, which includes pain originating from a toothache.


Q: What is the risk of dependence or addiction with Algi-Reumatril?

Algi-Reumatril, which contains Ibuprofen, is a non-opioid NSAID. Regulatory bodies confirm that medications in this pharmacological class are not associated with a risk of physical dependence or addiction.


Q: Is Algi-Reumatril used for pain following minor surgery?

Ibuprofen is generally indicated for mild to moderate pain. However, regulatory warnings note it is strictly contraindicated for use immediately following Coronary Artery Bypass Graft (CABG) surgery, and its use for other types of post-surgical pain requires guidance from a healthcare professional.


Q: Does Algi-Reumatril have any effect on blood clotting?

Yes, Ibuprofen is known to interfere with thromboxane, which results in a mild slowing of the body's natural blood clotting time. While it is not a primary blood thinner, this effect increases the risk of bleeding, especially when combined with other medicines that also affect clotting.

Advertisements

How should Algi-Reumatril be stored and disposed of?

How to Store and Dispose of Algi-Reumatril

The storage and disposal instructions for Algi-Reumatril (Ibuprofen tablets) are governed by official regulatory requirements to maintain product stability and ensure environmental safety.

Official Storage Requirements

Condition Regulatory Requirement
Temperature Store below 25^circC (or 30^circC) and protect from excessive heat.
Protection Keep in the original container or outer carton to shield from light and moisture.
Child Safety Must be kept strictly out of the sight and reach of children.
Stability Do not use the medicine after the expiry date printed on the packaging.

Official Disposal Rules

Regulatory agencies instruct that this medicine must not be disposed of via wastewater or household trash. Unused or expired Algi-Reumatril tablets should be returned to a pharmacist or a certified drug take-back point for proper pharmaceutical waste handling according to local environmental requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Algi-Reumatril found in:

A-Z Index: